- Pathological changes of the rectum that are located up to 5cm above the anocutaneous line, or that would not provide the required safety margin to the aboral resection margin in the case of a suprasphincteric anastomosis as part of a low anterior rectal resection; the illustrated surgical technique is in the border area between low anterior rectal resection and abdominoperineal extirpation.
- The operation includes a total mesorectal excision with resection of the internal sphincter as well as a coloanal anastomosis under stoma protection.
- This sphincter-preserving surgical procedure that avoids amputation requires a neorectal reconstruction through a colon pouch procedure. This shows a positive effect on postoperative bowel function.
When choosing between continence-preserving surgery and extirpation, both oncological and functional aspects must be considered.
Despite the central importance of the surgery, interdisciplinary therapy planning in the context of a multidisciplinary tumor conference is particularly important for carcinoma of the lower third of the rectum. Thus, through the use of long-term radiochemotherapy, a significant tumor reduction, often even downstaging, can be achieved, and smaller aboral resection margins, up to 0.5 cm, can be accepted, which often makes preservation of the bowel continuity possible in the first place. However, larger safety margins are recommended for poorly differentiated tumors (G3, G4).
The most important prognostic factor after oncological interventions is the resection of the tumor and the lymphatic drainage area while maintaining a >1 mm wide distance to the circumferential resection margin. The circumferential resection margin (CRM) describes the smallest distance from the tumor to the lateral resection margin, regardless of whether it is the primary tumor or another intramesorectal tumor manifestation such as tumor-involved lymph nodes or extramural vascular invasion. A positive CRM is generally documented as a distance of 1 mm or less.
Both criteria (aboral and circumferential) resection margin are significantly more difficult to achieve in carcinomas of the lower third of the rectum than in higher located tumors, which is reflected in poorer specimens and in particular a higher local recurrence rate. The reason for this lies primarily in the anatomical peculiarities.
Continuity-restoring reconstructions should generally be protected by a protective stoma due to the high rate of insufficiencies of the coloanal or intersphincteric anastomoses.
In the illustrated example, it is a juxta-anal located carcinoma of the lower third of the rectum. A partial intersphincteric resection is performed up to the level of the dentate line. The anastomosis is performed after forming a coloplasty pouch as a coloanal hand suture.
Functional Aspects
In addition to the technical feasibility from an oncological perspective, functional aspects are crucial for the decision on continence preservation in low-seated carcinomas. Continuity preservation is not necessarily equal to continence preservation. About half of all patients with a low anterior rectal resection develop a „low anterior resection syndrome“ (LARS), which is characterized by an increased stool frequency with fractionated emptying, urgent bowel urge, and incontinence for gas or liquid stool. In addition, many patients suffer from significant problems with bowel emptying, which also has a considerable negative impact on quality of life. Patients with continence-preserving resections and anastomoses ≤5 cm are more restricted in terms of quality of life than patients with higher located tumors.
The pretherapeutic assessment of the later function is difficult. The functional result becomes more critical with every centimeter that moves the anastomosis closer to the dentate line. Even in cases of preexisting incontinence, one should exercise the greatest restraint regarding the performance of a continuity-preserving operation. The decision for or against continence preservation in low-seated rectal carcinoma for functional reasons is almost always an individual decision, which must be discussed openly with the patient before the surgery.
Neoadjuvant Radiation Therapy
Neoadjuvant radiation therapy can be administered with and without chemotherapy and is recommended according to the S3 guidelines for rectal carcinoma in UICC stages II (pT3-4 pN0) and III (pT1-4 pN+).
Neoadjuvant radiochemotherapy (RCT) lasts about 6 weeks, followed by a therapy break of 6-8 weeks until surgery.
Neoadjuvant short-term radiation (RT) is administered on 5 consecutive days. Here, the surgery takes place after 2-7 days. Since tumor downsizing is not to be expected, RCT is preferred for tumors that reach the enveloping fascia or are located near the sphincter.
27% of patients show a histological complete remission through RCT. These patients have a particularly good oncological prognosis. Since response assessment is difficult and requires a DRE (digital rectal examination), an endoscopy, and an MRI for detection, a „watch-and-wait“ strategy can only be applied to tumors up to 7cm from the anus and preferably in studies.

